Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Device Briefing Tool and Surgical Safety Checklist Implementation

22 de novembro de 2021 atualizado por: James Etheridge

Safe Introduction of a New Surgical Device With the Device Briefing Tool and Surgical Safety Checklist in Singapore

The investigators aim to implement a quality improvement initiative using the device briefing tool (DBT) and the Safe Surgery Checklist (SSC) and to evaluate its effect on patient safety measures and on safety culture with the introduction of a new surgical device in Singapore hospitals. Within eligible hospitals, J&J and Ariadne Labs staff will train local implementation teams to, in turn, train operating room teams to use the DBT and SSC. Project-specific outcomes will be measured by neutral observers and via survey data. Throughout the quality improvement initiative, hospitals will receive ongoing training and coaching on their interventions and feedback on their outcomes.

Visão geral do estudo

Descrição detalhada

Design of Quality Improvement Initiative Using a prospective observational implementation design, surgical teams will be assigned to 1 of 2 groups. Group I will receive the complete intervention, which includes implementation of the DBT from the start, and then the DBT and SSC package.

Group II does not receive the DBT alone; these teams continue with their usual care, and then receive the DBT and SSC package.

Device-related interruptions, non-technical skills of surgical teams, and Culture of Safety Survey will be measured pre- and post-implementation of the SSC and DBT interventions, with specific timing depended on group allocation. OR teams at each hospital will be observed longitudinally to assess the effects of the DBT and SSC interventions.

Target Population for the Quality Improvement Initiative Participants will be members of the OR team at each participating hospital. These members include practicing surgeons, anesthesiologists, OR nurses, and OR staff. Hospitals will be participating institutions of SingHealth and NUHS hospital clusters. J&J device sales representatives ("reps") will serve as key trainers during the multidisciplinary trainings to use the DBT during an operation. A separate implementation team will be trained by Ariadne Labs to execute the SSC at each eligible hospital. Hospital leadership will be key stakeholders to engage at each hospital in order to implement the DBT, team training, and SSC program.

Interventions Device Briefing Tool: a 4-item mini-checklist focused on raising OR team awareness to the nuances of a new surgical device.

Trained J&J sales reps will be responsible for training OR teams to use the DBT with the new surgical device. Ariadne Labs will provide initial training to the J&J reps and be available for ongoing training support.

Safe Surgery Checklist: Developed with the World Health Organization, the SSC is a 19-item checklist consisting of verbal confirmation by surgical teams of the completion of the basic steps for ensuring the safe delivery of anesthesia, prophylaxis against infection, effective teamwork, among other essential practices in surgery. As described elsewhere in greater detail, it is used at 3 critical junctures of care: before anesthesia is administered, immediately before incision is made, and before the patient is taken out of the operating room. A successful implementation of the SSC is a labor-intensive iterative process that includes 4 phases: prepare, own, expand, and improve.

Ariadne Labs will provide the specialists needed to implement the SSC and to support local hospitals' implementation teams. Please refer to the SSC Implementation Guide for process details in the Supplemental Materials.

Outcomes to Study Device-related interruptions: Any interruption in the surgical team's workflow as the result of the use of the study device.

Non-technical skills: Evaluation of OR team performance for non-technical skills (situation awareness, decision-making, cooperation and teamwork, and leadership), using the NOTECHS assessment, a validated rating system for intraoperative OR team behavior.

Perception of safety, i.e. "safety culture": The perception of safety among members of the OR team will be measured using the Culture of Safety Survey.

Site readiness assessment: We will evaluate the readiness capacity of institutions to implement the DBT/SSC intervention using the Readiness Assessment Tool.

Goal: Determine if the pre-intervention Readiness Assessment Tool is predictive (R2 > 0.7) of implementation success as gauged by the post-intervention Implementation Survey.

Feasibility of scale: The scale of this project will be measured by the number of personnel trained, the number of hospitals at which the DBT, team training, and SSC intervention is implemented, and adherence rates to the intervention.

Tipo de estudo

Observacional

Inscrição (Real)

294

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Singapore, Cingapura
        • Singapore General Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra Não Probabilística

População do estudo

All surgical teams operating in participating SingHealth hospitals will be eligible. Surgical teams include surgeons, anesthetists, nurses, and (in some cases) ancillary providers. The patient is not included as a member of the surgical team. Patients are not being evaluated as part of this study.

Descrição

Inclusion Criteria:

  • Surgical teams in SingHealth hospitals

Exclusion Criteria:

  • Refusal by any team member to participate

Note - there are NO specific age criteria, since the unit of analysis is the surgical team rather than the patient. It is highly unlikely that any surgical team member would be less than 18 years of age or greater than 89 years of age, but there are no explicit age-based exclusions.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

Coortes e Intervenções

Grupo / Coorte
Intervenção / Tratamento
Device Briefing Tool Implementation
Surgical departments which receive training on use of the Device Briefing Tool
A 4-item supplement to the WHO Surgical Safety Checklist designed to improve teamwork and communication around new/complex surgical devices
Reimplementation of the WHO Surgical Safety Checklist to improve adherence and utility of the checklist
Comparator
Surgical departments that do not receive training on use of the Device Briefing Tool
Reimplementation of the WHO Surgical Safety Checklist to improve adherence and utility of the checklist

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Oxford NOTECHS scale
Prazo: Change in NOTECHS scores will be assessed from baseline to immediately after DBT implementation and 2-months after SSC implementation
Measure of non-technical skills of surgical teams assessed by neutral observers. Scored 12-48 with higher scores indicating better non-technical skills.
Change in NOTECHS scores will be assessed from baseline to immediately after DBT implementation and 2-months after SSC implementation

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Device-related interruptions (DRIs)
Prazo: Change in DRIs will be assessed from baseline to immediately after DBT implementation and 2-months after SSC implementation
The number of times surgical teams must cease activity due to a problem with a surgical device
Change in DRIs will be assessed from baseline to immediately after DBT implementation and 2-months after SSC implementation
Culture of safety
Prazo: Change in safety culture from baseline will be assessed 2-months post-SSC
Safety culture, as measured by division-wide Hospital Survey on Patient Safety Culture (HSOPS) survey. HSOPS is scored from 0 to 100% with higher scores indicating better safety culture.
Change in safety culture from baseline will be assessed 2-months post-SSC

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Investigadores

  • Investigador principal: Joaquim Havens, MD, Ariadne Labs

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

1 de novembro de 2019

Conclusão Primária (Real)

30 de junho de 2021

Conclusão do estudo (Real)

30 de junho de 2021

Datas de inscrição no estudo

Enviado pela primeira vez

18 de outubro de 2021

Enviado pela primeira vez que atendeu aos critérios de CQ

5 de novembro de 2021

Primeira postagem (Real)

17 de novembro de 2021

Atualizações de registro de estudo

Última Atualização Postada (Real)

24 de novembro de 2021

Última atualização enviada que atendeu aos critérios de controle de qualidade

22 de novembro de 2021

Última verificação

1 de novembro de 2021

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • IRB19-0389

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever